# CAN SLIM Progress Board

Last updated: 2026-09-12

Frozen quantitative v1 remains research-complete but not production-ready. FWD1 and EXH2 continue unchanged. The post-v1 Theory Fidelity Audit (#25-#31) is now complete and must not alter frozen v1/FWD1 semantics.

## Canonical v1 state

| Area | Status | Note |
|---|---|---|
| Independent CAN SLIM project | COMPLETE | separate from TrendFoll |
| Frozen Musaffa universe | COMPLETE / FROZEN | 1,327 current-compliant securities |
| Production OHLCV / data infrastructure | COMPLETE | existing R2 daily OHLCV is the technical-data basis |
| SEC/PIT fundamentals | COMPLETE / FROZEN | upstream `ussy-fundamentals` |
| C / A | COMPLETE | PIT-safe historical attachment validated |
| N / S / L proxies | COMPLETE | v1 proxy semantics frozen |
| I institutional sponsorship | COMPLETE / NOT PROMOTED as hard filter | descriptor retained |
| M / SPY+QQQ ablation | COMPLETE / NOT PROMOTED | v1 evidence frozen |
| Historical candidates v1 | COMPLETE | 10,731 / 860 securities; proxy candidates, not O'Neil ground truth |
| X1-X4 / X3 | COMPLETE / PARKED | historical v1 work complete; no current entry optimization |
| PORT1 / costs / robustness | COMPLETE | retrospective evidence frozen |
| CAN SLIM quantitative v1 | **RESEARCH COMPLETE** | historical economics weak vs passive SPY |
| FWD1 | LIVE / ACCUMULATING | frozen forward validation |
| EXH2 | LIVE / PROSPECTIVE | separate exhaustion sidecar |
| Production integration | BLOCKED | FWD1 review gate not met |

Historical v1 reference remains approximately X3 PF 1.163, PF ex-top10 1.145, PORT1 gross CAGR 3.02–3.04%, gross max DD -43.36%, and SPY price-only CAGR context ~8.80%. These figures must not be used to tune the theory-fidelity track.

## Theory Fidelity / v2 path — #25 onward

| # | Workstream | Status |
|---:|---|---|
| 25 | Theory Fidelity Audit — O'Neil vs engine v1 | **COMPLETE** |
| 26 | Proper-base definitions | **COMPLETE** |
| 27 | Pivot / buy-point definition | **COMPLETE** |
| 28 | Breakout + volume confirmation | **COMPLETE** |
| 29 | RS / leadership fidelity | **COMPLETE** |
| 30 | C/A/S/I/M role fidelity | **COMPLETE** |
| 31 | Sell / risk-management fidelity | **COMPLETE** |
| 32 | **Theory-faithful candidate specification** | **NEXT** |
| 33 | **O'Neil Pattern Recognition Engine** | NOT STARTED |
| 34 | Theory-faithful candidate generator | NOT STARTED |
| 35 | New-candidate validation | NOT STARTED |
| 36 | Execution / entry research | **PARKED** |

### #26 Proper Base
**WEAK_PROXY** for v1. Generic prior-35-session/depth<=40% consolidation does not identify O'Neil morphology. Core future structures include CWH, cup without handle, double bottom and flat base, with base-on-base, ascending base and IPO-base special structures preserved.

### #27 Pivot / Buy Point
**WEAK-to-REASONABLE_PROXY** for v1. Pivot is pattern-specific structural resistance, not an arbitrary rolling high. CWH uses handle high; cup without handle prior/left high; double bottom middle W peak; flat base base/left high; ascending base final/pattern resistance; base-on-base derives pivot from the second base.

### #28 Breakout + Volume Confirmation
**REASONABLE_PROXY** overall for v1. `Volume >=1.40x prior-50d avg` is high fidelity; `Close > pivot` is an over-strict hold proxy; the 5% cap is an execution/extension concept rather than breakout identity. Preserve pivot-cross event, close/hold quality, initial vs later volume confirmation, and gap state separately.

### #29 RS / Leadership Fidelity
**REASONABLE_PROXY, INCOMPLETE** for v1. RS Rating and RS line are distinct; `RS>=80` is a faithful general leader screen but not complete `L`. RS-line confirmation/divergence and industry leadership remain missing. Do not claim v1's 40/20/20/20 score replicates current 2026 IBD RS methodology.

### #30 C/A/S/I/M Role Fidelity
CAN SLIM letters do not share one Boolean role. C/A are primarily fundamental screens; S/I are evidence/confirmation layers; M is market context plus entry-timing/risk gate. Historical proxy ablations do not redefine theoretical roles.

### #31 Sell / Risk-Management Fidelity
**COMPLETE. v1 does not contain a canonical O'Neil sell engine.** Frozen theory findings:

- protect capital first; historical O'Neil/IBD maximum loss is roughly **7%-8% from actual purchase price**, with current practical IBD guidance commonly using ~7% and earlier exits possible in weak markets;
- failed breakouts and technical deterioration are additional evidence; a decisive **50-day/10-week break on heavy volume** is a major institutional-selling signal;
- normal profit management begins around **+20%-25% from the proper buy point**;
- if a stock reaches **+20% within the first 1-3 weeks after breakout**, preserve the **eight-week hold exception** for potential exceptional leaders;
- preserve a **round-trip** state when a meaningful/double-digit gain is surrendered back to the buy point;
- climax-top/exhaustion behavior is a contextual late-stage sell state, not one arbitrary threshold; EXH2 remains separate prospective research and is not relabeled as the O'Neil sell engine;
- stock-level sell state, market-level exposure reduction, position sizing, stop policy and execution mechanics are separate contracts.

Canonical detail for #26-#31: `docs/methodology/oneil-theory-fidelity-audit-v1.md`.

## #25 consolidated close
The theory audit is now closed. Frozen quantitative v1 is classified as a **transparent CAN SLIM-inspired proxy research system**, not a faithful reconstruction of O'Neil/IBD. Strongest fidelity: breakout-volume confirmation and general RS percentile leadership screening. Largest gaps: proper-base morphology, pattern-specific landmarks/pivots, RS-line/group context, role semantics across letters, and canonical sell/risk discipline.

## #33 — O'Neil Pattern Recognition Engine
Pattern recognition remains a dedicated workstream after #32. It will use existing daily OHLCV in R2 for candidate-base segmentation, swing/landmark extraction, CWH/cup-no-handle/DB/flat/ascending detectors, base-on-base state, faulty-base flags, ambiguity/confidence handling and morphology validation. It must not start before #32 and must not optimize morphology against CAGR/PF.

## Forward tracks remain frozen
FWD1 boundary remains exclusive 2026-09-09 with formal review only after both >=12 completed calendar months and >=50 closed X3 portfolio trades. EXH2 remains separate and prospective. Theory-fidelity findings must not be retrofitted into either track.

## Active work from here
1. **Execute #32 Theory-Faithful Candidate Specification.**
2. Freeze the specification before implementation.
3. Only after #32, begin #33 Pattern Recognition Engine using R2 OHLCV.
4. Then #34 candidate generator and #35 morphology/candidate validation.
5. Keep #36 execution/entry research parked and keep FWD1/EXH2 accumulating unchanged.
6. Do not tune theory/pattern/breakout/RS/fundamental/sell rules from historical or interim forward performance.